Comparison of two chromogenic media for the detection of vancomycin-resistant enterococcal carriage by nursing home residents by Gouliouris, Theodore et al.
Diagnostic Microbiology and Infectious Disease 85 (2016) 409–412
Contents lists available at ScienceDirect
Diagnostic Microbiology and Infectious Disease
j ourna l homepage: www.e lsev ie r .com/ locate /d iagmicrob ioComparison of two chromogenic media for the detection of
vancomycin-resistant enterococcal carriage by nursing home residentsTheodore Gouliouris a,b,c,⁎, Beth Blane a, Hayley J. Brodrick a, Kathy E. Raven a, Kirsty E. Ambridge a,
Angela D. Kidney a, Nazreen F. Hadjirin d, M. Estée Török a,b,c, Direk Limmathurotsakul e, Sharon J. Peacock a,c,e,f
a Department of Medicine, University of Cambridge, Cambridge, United Kingdom
b Public Health England, Clinical Microbiology and Public Health Laboratory, Cambridge, United Kingdom
c Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
d Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom
e Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
f London School of Hygiene & Tropical Medicine, Keppel Street, London, United Kingdom
a b s t r a c ta r t i c l e i n f o⁎ Corresponding author. Tel.: +44-1223-336867; fax: +
E-mail address: theo.gouliouris@doctors.org.uk (T. Go
http://dx.doi.org/10.1016/j.diagmicrobio.2016.04.026
0732-8893/© 2016 The Authors. Published by Elsevier IncArticle history:
Received 26 January 2016
Received in revised form 19 April 2016
Accepted 23 April 2016
Available online 4 May 2016
Keywords:
Vancomycin-resistant enterococci
VRE
Enterococcus faecium
Detection
Sensitivity
SelectivityWe compared ChromID VRE and Brilliance VRE media for the detection of vancomycin-resistant
enterococci (VRE). Using a panel of 28 enterococcal isolates, 10 vanA Enterococcus faecium and three vanA
Enterococcus faecalis isolates grew as per manufacturers’ instructions whilst growth of two vanC and eight
vancomycin-susceptible enterococci was inhibited on both media. Important differences were noted in the
selectivity and chromogenic properties of the two media for vanA Enterococcus raffinosus and vanB E. faecium.
The two media were further evaluated using 295 stool samples from nursing home residents, 34 of which
grew VRE (11.5%). ChromID and Brilliance had comparable sensitivity, which was increased markedly
by prolonging incubation to 48 hours (from 29% to 82%, and from 41% to 85%, respectively) and by a pre-
enrichment step (to 97% and 100%, respectively). Brilliance VRE agar had higher selectivity at 48 hours, and
after pre-enrichment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Vancomycin-resistant enterococci (VRE) are an important cause of
healthcare-associated infections in Europe and USA, mainly attributed to
the global dissemination of hospital-adapted lineages of vanAmediated
vancomycin-resistant Enterococcus faecium (VREfm) (Hidron et al.,
2008; Lebreton et al., 2013; Werner et al., 2008). In the UK, mandatory
surveillance reported 6,246 episodes of VRE bacteremia from 2003 to
2012, with an annual incidence that has failed to decline despite the im-
plementation of infection control interventions that successfully curtailed
rates of methicillin-resistant Staphylococcus aureus bacteremias and Clos-
tridium difficile infections (Gouliouris and Peacock, 2014). VRE are a lead-
ing cause of bacteremia in some immunocompromised populations, and
are associated with increased mortality and costs compared with infec-
tions caused by vancomycin-susceptible enterococci (Butler et al., 2010;
DiazGranados et al., 2005; Prematunge et al., 2016).
Screening for fecal carriage of VRE has been advocated as part of a
bundle of interventions used to control outbreaks in healthcare settings44-1223-336846.
uliouris).
. This is an open access article under(Cookson et al., 2006; Siegel et al., 2006), and is routinely used in some
units for active surveillance (Brown et al., 2006). Chromogenic media fa-
cilitate the early detection of VRE compared to traditional selectivemedia
(Asir et al., 2009; Cuzon et al., 2008; Delmas et al., 2007; Grabsch et al.,
2008; Jenkins et al., 2011; Peterson et al., 2010), but there is little data
comparing the performance of different commercial chromogenic
media (Peltroche-Llacsahuanga et al., 2009; Suwantarat et al., 2014). In
a recent comparison of five chromogenic media for the detection of VRE
in stool, chromID VRE agar (bioMérieux) had the highest sensitivity, al-
though the differences were not statistically significant (Suwantarat
et al., 2014). However, Brilliance VRE (Oxoid) was not included in this
evaluation and chromogenic media were not assessed under different
culture conditions such as using pre-enrichment. In addition, no com-
parative studies have been conducted outside the hospital setting
where optimising culture conditions to maximise yield would be im-
portant for the accurate determination of VRE stool carriage and
epidemiology.
The aims of this method comparison study were to assess the
sensitivity and selectivity of chromID VRE and Brilliance VRE
i) evaluated against a diverse collection of enterococci with previously
characterized resistance mechanisms; ii) and tested with or without
pre-enrichment using fecal samples from residents of a nursing home
in Cambridgeshire.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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2.1. Bacterial isolates
A collection of previously characterized isolates of E. faecium (n =
13), Enterococcus faecalis (n = 11), Enterococcus gallinarum, Enterococ-
cus casseliflavus, Enterococcus raffinosus and Enterococcus hirae was se-
lected for testing. The isolates originated from NCTC collections (n =
12), a retrospective collection of bacteremia isolates from Cambridge
University Hospitals (CUH) NHS Foundation Trust (2006–2012, n =
15), and from a meat sample (n = 1) (Table 1). They included isolates
with vanA and vanB acquired resistance, and in the case of E. faecalis
and E. faecium bacteremia isolates, a range of diverse hospital-adapted
STs Raven, Reuter, Gouliouris, et al., 2016; Raven, Gouliouris, et al.,
2016 (under review)). The organisms were grown from glycerol bead
vials stored at−80°C onto Columbia blood agar (CBA, Oxoid) and 200
μl of a 0.5 McFarland suspension was streaked using the four-quadrant
technique onto chromID VRE agar (bioMérieux) and Brilliance VRE agar
(Oxoid). Growth was assessed after 24 and 48 hours aerobic incubation
at 37 °C. Vancomycin minimum inhibitory concentration was measured
using Etest (bioMérieux).2.2. Nursing home study setting and design
The studywas conducted as part of a larger prospective longitudinal
VRE gut carriage survey of residents in a single nursing home in
Cambridgeshire (Brodrick et al., 2016). Written informed consent was
obtained from participants or consultees, as appropriate. The study
protocol was approved by the National Research Ethics Service East
of England Ethics Committee (NRES ref: 13/LO/1278), and the CUH
Research and Development Department (ref: A093007).Table 1
Performance of two chromogenic agars tested against a panel of 28 diverse enterococci.
Isolate Species van gene Vancomycin MIC S
EC0041 E. faecium vanA N256 1
EC0179 E. faecium vanA N256 6
EC0212 E. faecium vanA N256 7
EC0180 E. faecium vanA N256 1
EC0115 E. faecium vanA N256 2
EC0051 E. faecium vanA N256 2
EC0518 E. faecium vanA N256 3
EC0220 E. faecium vanA N256 4
EC0176 E. faecium vanA N256 5
NCTC12202 E. faecium vanA N256 1
EC0050 E. faecalis vanA N256 1
NCTC12201 E. faecalis vanA N256 2
NCTC12203 E. faecalis vanA N256 6
EC0109 E. raffinosus vanA N256
VREN1021 E. hirae vanA 128
EC0181 E. faecium vanB N256 2
NCTC12952 E. faecium vanB 24 1
NCTC13379 E. faecalis vanB 16 6
NCTC12362 E. casseliflavus vanC 3
NCTC12360 E. gallinarum vanC 4
NCTC7378 E. faecium - 0.75 3
EC0439 E. faecalis - 1.5 6
EC0441 E. faecalis - 1 1
EC1246 E. faecalis - 1 2
NCTC8131 E. faecalis - 2 2
NCTC775 E. faecalis - 0.38 2
NCTC8175 E. faecalis - 2 4
NCTC8132 E. faecalis - 2 5
Growth was quantified as + (growth in all four quadrants), poor (scanty growth inmore than
ance was as per manufacturers’ instructions for E. faecalis and E. faecium. For other species, the
MIC, minimum inhibitory concentration (mg/L).2.3. Sample collection, media and culture conditions
A total of 295 stool samples were collected from 37 participants,
with a median number of samples per subject of 8 (range 1–14, inter-
quartile range 5–11). Stool samples were collected at study entry and
then every week for 14 weeks, starting in March 2014. Stool samples
were processed in the laboratory within 24 hours, except for samples
obtained over the weekend, which were refrigerated and processed
within 72 hours. We performed direct plating onto chromID VRE agar
and Brilliance VRE agar, and plating onto both media after a selective
pre-enrichment step. For direct plating, a pea-sized amount of stool (ap-
proximately 0.2 g) was homogenized in 2 ml of Brain Heart Infusion
broth (BHIB, Merck), from which 200 μl was inoculated onto each of
the chromogenic agar. The remaining homogenate was made up to
5 ml BHIB with a final concentration of 3 mg/L of vancomycin (Sigma)
and incubated with shaking at 150 rpm at 37 °C aerobically overnight.
Two hundred μl of this broth was then inoculated onto each chromo-
genic agar. All chromogenic agar plates were incubated at 37 °C in air
and read at 24 and 48 hours.
Colonies with an appearance consistent with the two target
species vancomycin-resistant E. faecalis (VREfs) and VR E. faecium
(VREfm) as per the manufacturers’ instructions were followed up by
subculture of a single colony of each phenotype on CBAwith a 5 μg vanco-
mycin disc (Oxoid). Enterococci from subcultures were confirmed to
species level using matrix-assisted laser desorption/ionisation time-of-
flight mass spectrometry (MALDI-TOF MS, Biotyper 3.1, Bruker Daltonics).
Antimicrobial susceptibility testing including vancomycin and teicoplanin
was performed using the AST-P607 card on the Vitek 2 instrument
(bioMérieux) calibrated against European Committee on Antimicrobial
Susceptibility Testing breakpoints (EUCAST, 2014). Colonies with an
atypical phenotype were evaluated by Gram stain, microscopy and
MALDI-TOF MS as required.T type ChromID VRE Brilliance VRE
24 hours 48 hours 24 hours 48 hours
7 + + + +
4 + + + +
8 + + + +
17 + + + +
02 + + + +
03 + + + +
75 + + + +
12 + + + +
52 + + + +
8 + + + +
03 + + + +
8 + + + +
+ + + +
colorless + colorless + + +
+ + + +
03 + + very poor poor
8 + + very poor poor
+ + + +
- - - -
- - - -
61 - - - -
- - - -
03 - - - -
8 - - - -
1 - - - -
5 - - - -
0 - - - -
5 - - - -
one quadrant) and very poor (scanty growth on primary inoculum only). Colonial appear-
colonial morphology was similar to E. faecium unless stated otherwise.
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Bacterial species identification, ST, and the presence of van genes
were confirmed from whole genome sequence data (Brodrick et al.,
2016). DNA was extracted using the QIAxtractor (QIAgen), according
to the manufacturer’s instructions. Library preparation was conducted
according to the Illumina protocol, and sequencing was performed on
an Illumina HiSeq2000 with 100-cycle paired-end runs. Molecular con-
firmation of the van genes was sought by in silico PCR using published
primers (Depardieu et al., 2004; Dutka-Malen et al., 1995).
2.5. Statistical analysis
Sensitivity of detection of VRE was calculated by comparing the
number of positive plates for a given method with the cumulative
yield of VRE from all four methods (direct plating onto two media,
and plating onto both following a pre-enrichment step). Selectivity for
each method was defined as the number of plates that suppressed the
growth of organisms that were not VREfs or VREfm. Statistical analysis
was performed using STATA, version 12.1 (STATA, College Station,
Texas, USA). Sensitivity and selectivity were compared using the exact
McNemar test.
3. Results
3.1. Evaluation study against characterized enterococcal isolates
The selectivity and chromogenic features of chromID and Brilliance
were evaluated against a panel of 28 enterococcal isolates (Table 1).
Both media inhibited the growth of vanC enterococci and vancomycin-
susceptible E. faecium and E. faecalis. Growth of vanA VREfs and VREfm
was observed for all tested isolates as per manufacturers’ instructions.
vanB VREfm grew well on chromID but showed poor growth on
Brilliance (small scanty colonies), particularly at 24 hours. Both media
supported the growth of non-target vanA VRE species, namely E. raffinosus
and E. hirae. E. raffinosus grew as colorless colonies on chromID but as
purple colonies resembling VREfm on Brilliance. By contrast, E. hirae
was indistinguishable in appearance from VREfm on both media.
3.2. Evaluation of sensitivity and selectivity in nursing home study
Target organisms were isolated from 34/295 (11.5%) stool samples,
all of whichwere ampicillin-resistant E. faecium and of the VanA pheno-
type based on Vitek 2 results and their colonial morphology matched
the manufacturers’ description. Presence of the vanA gene was con-
firmed for all 34 isolates. The isolates originated from 3 of 37 residents
(8.1%) who were positive on at least one occasion (range 6–14Table 2
Sensitivity and selectivity of two chromogenic agars for the isolation of vancomycin-resistant e
ChromID VRE
direct plating
Method 1
Incubation time (hours) 24 48
Number of plates growing VREa 10 28
Sensitivityb 29% 82%
Number of plates NOT growing organisms other than VREa 292 277
Selectivityc 99% 94%
Number of plates growing Gram-negative organisms 3 10
Number of plates growing Gram-positive organisms 0 6
Number of plates growing yeasts 0 2
VRE = vancomycin-resistant enterococci.
a Target VRE organisms consisted of vancomycin-resistant E. faecalis (VREfs) and vancomyci
b Sensitivitywas calculated by comparing the number of positive plates for a givenmethod, c
onto two media, and plating onto both following a pre-enrichment step, n = 34).
c Selectivity for each method was defined as the number of plates that suppressed the growsamples). Four ST typeswere identified (18, 80, 203, and 787, all belong-
ing to the clonal expansion of clade A).
Detection of VREwas comparable between the twomedia for all four
methods (Table 2, all P N 0.10). Sensitivity of detection following direct
plating was increased when incubated for the longer duration of 48
hours (from 29% to 82% for chromID agar, P b 0.0001 and from 41% to
85% for Brilliance agar, P=0.0001). Pre-enrichmentwith 48 hours incu-
bation further increased the sensitivity of detection of VRE (from 82% to
97% for chromID agar, P=0.06 and from 85% to 100% for Brilliance agar,
P=0.03). Therewas a trend for Brilliance agar to bemore selective than
chromID media at 48 hours after direct plating (97% vs. 94%, P= 0.05).
Selectivity of Brilliance agar was significantly higher than that of
chromID agar at both 24 hours (95% vs. 88%, P= 0.002) and 48 hours
(92% vs. 77%, P b 0.0001) after pre-enrichment. Selectivity of both plates
was poorer at 48 hours versus 24 hours after pre-enrichment (P =
0.0002 for Brilliance agar, and P b 0.0001 for chromID agar).
Gram-negative bacilli were the majority of non-target organisms
(false positives) encountered and accounted for most of the difference
in selectivity between the two media. Both manufacturers specify that
plates can be incubated for up to 48 hours and that a pre-enrichment
step can be used. Despite the differences in selectivity, non-target
organisms were easily distinguishable from VRE on both media based
on color and colonial morphology. However, vancomycin-resistant
Enterococcus avium was isolated as a colorless colony on chromID from
two samples originating from the same patient (but not from Brilliance).
Positive and negative predictive values for each culture method
before and after taking into account Gram stain results are shown in
Supplementary Tables 1 and 2. Specificity and positive predictive
value improved significantly for both media after taking into account
the Gram stain result.
4. Discussion
We compared the performance of chromID and Brilliance for the de-
tection of VRE. Testing fecal carriage in a nursing home population in
Cambridgeshire, the two media had comparable sensitivity for the isola-
tion of vanA VREfm, but Brilliance agar had higher selectivity than
chromID agar by suppressing growth of Gram-negative organisms. Sensi-
tivity was markedly increased for both media by prolonging the time of
incubation to 48 hours after direct plating, and by a pre-enrichment
step. A limitation of this studywas the absence of VREfs and vanBVRE de-
tection in this population, consistentwith vanAVREfmdominating theUK
epidemic (Cookson et al., 2006; Raven, Reuter, Gouliouris, et al., 2016;
Raven, Reuter, Reynolds, et al., 2016, [under review]), and the small num-
ber of positive patients, which reduced the diversity of positive isolates.
The sensitivity of direct culture at 24 hours was low for both media.
Previous studies report sensitivities of over 90% at 24 hours using VREnterococci from 295 stool samples.
Brilliance VRE
direct plating
Method 2
ChromID VRE
plating after
enrichment
Method 3
Brilliance VRE
plating after
enrichment
Method 4
24 48 24 48 24 48
14 29 32 33 33 34
41% 85% 94% 97% 97% 100%
293 285 259 227 280 270
99% 97% 88% 77% 95% 92%
2 5 28 58 11 18
0 4 6 7 4 6
0 1 2 3 0 1
n-resistant E. faecium (VREfm).
omparedwith the cumulative yield of VREfs or VREfm from all fourmethods (direct plating
th of organisms that were not VREfs or VREfm (out of all 295 samples).
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not use pre-enrichment as a comparator, or studied hospitalized populations
such as those in intensive care units where high load of VRE carriagemay be
expected. By contrast, two studies that used an additional pre-enrichment
step to evaluate chromID for the detection of VRE in hospitalized patients
also found a low sensitivity at 24 hours of around 50% (Asir et al., 2009;
Delmas et al., 2007). Decisions over time of incubation and the use of pre-
enrichment for a given application will be influenced by the relative
importanceof turn-around timeversus sensitivity andselectivityofdetection,
and will depend on population factors such as fecal carriage load.
We found significant differences in the performance of chromID and
Brilliance using rare vanA VRE species (non-faecalis or -faecium) and vanB
VREfm. Both media supported the growth of vanA E. raffinosus and
E. hirae, however the former could have been missed on chromID as it ap-
peared colorless. Conversely, vanA E. avium only grew on chromID. Whilst
the occurrence of these organisms is rare, they can potentially have a path-
ogenic role or act as sources of vancomycin resistance genes. Wijesuriya
et al. (2014) compared 4 chromogenic media including chromID and Bril-
liance in a small Australian studywhere stool sampleswere spikedpredom-
inantly with vanB VREfm. Brilliance appeared to have lower sensitivity
compared to other media in detecting VRE, particularly for those isolates
where the vancomycin MIC value was b16 mg/L. These results contrast
with the findings of Klare et al. (2012) who reported similar performance
between VRE Brilliance and chromID against a panel of 129 vanB E. faecium
isolates. We found that the two vanB VREfm isolates with different vanco-
mycinMICs (24 and N256mg/L) produced slower growth onVRE Brilliance
compared to chromID. This effect could not be explained solely by the MIC
values, as the vanB VREfs isolate which had a lower MIC (16 mg/L) grew
well on both media. We would caution against using Brilliance in a setting
whereVREfm ispredominantlymediatedbyvanBuntil further comparative
data is available from clinical studies.
In conclusion, the combination of highest sensitivity and selectivity
was achieved by Brilliance agar with a pre-enrichment step and 48
hours incubation after plating when evaluated in a nursing home popu-
lation with predominantly vanA VREfm carriage.
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